Skip to main content
Advanced Science logoLink to Advanced Science
. 2025 May 26;12(30):e07227. doi: 10.1002/advs.202507227

Correction to “Sequential Targeting Chondroitin Sulfate‐Bilirubin Nanomedicine Attenuates Osteoarthritis via Reprogramming Lipid Metabolism in M1 Macrophages”

PMCID: PMC12376504  PMID: 40418112

Deng C, Xiao Y, Zhao X, et al. Sequential Targeting Chondroitin Sulfate‐Bilirubin Nanomedicine Attenuates Osteoarthritis via Reprogramming Lipid Metabolism in M1 Macrophages. Advanced science, 2025 Mar;12(9):e2411911.

In Figure 5E, the co‐immunostaining images of cell staining for the PBS, LCF, and LCF‐PEGBN groups were incorrectly presented due to improper panel preparation during ImageJ processing. We have since verified the original data and replaced the images in Figure 5E (PBS, LCF, and LCF‐PEGBN) with the correct versions, as presented below.

graphic file with name ADVS-12-e07227-g001.jpg

This correction does not affect the overall findings and conclusions of this paper. We apologize for this error.


Articles from Advanced Science are provided here courtesy of Wiley

RESOURCES